Not yet recruiting NCT07015788

Open -Label,Cross Over Trail Evaluating the Glycemic Impact of Peach Varieties in Healthy Adullts

No phase Interventional Blood Glucoe

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: The protocol lists: EARLY GRAND, SPRING CREST PEACH, INDIAN BLOOD.
Who it may be relevant to: Registry conditions: Blood Glucoe. Basic parameters: 18 years — 50 years · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: Pakistan
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

This study aims to evaluate the effect of different peach varieties on the glycemic index (GI) in healthy adult participants. While peaches are generally classified as low-GI fruits, variations in sugar composition, fiber content, and ripeness among different cultivars may influence their glycemic response. By assessing and comparing the GI values of several commonly consumed peach varieties, this trial seeks to provide more precise dietary recommendations for glycemic control and support better fruit selection for individuals managing blood glucose levels.

Detailed description

Interventions

Other EARLY GRAND
Participants will consume a standardized portion of peach variety A containing 50 grams of available carbohydrates. Capillary blood glucose levels will be measured at multiple time points post-consumption to assess glycemic response.
Other SPRING CREST PEACH
Participants will consume a standardized portion of peach variety B containing 50 grams of available carbohydrates. Capillary blood glucose levels will be measured at multiple time points post-consumption to assess glycemic response.
Other INDIAN BLOOD
Participants will consume a standardized portion of peach variety C containing 50 grams of available carbohydrates. Capillary blood glucose levels will be measured at multiple time points post-consumption to assess glycemic response.

Primary outcome measures

Glycemic Index [Time frame: 2 hours post-consumption (per intervention)]

Secondary outcome measures (2)

Incremental Area Under the Curve (iAUC) for Blood Glucose [Time frame: 0-120 minutes post-consumption]
Peak Blood Glucose Concentration [Time frame: 0-120 minutes post-consumption]

Eligibility criteria

Inclusion Criteria:• Healthy male and female adults aged 18-50 years

BMI between 18.5-24.9 kg/m²
Normal fasting blood glucose (<100 mg/dL)
Willingness to adhere to the study protocol Exclusion Criteria:• Diagnosed diabetes, metabolic syndrome, or any glucose metabolism disorder
Use of medications or supplements that affect glucose levels
Allergy to peaches or intolerance to test/reference foods
Pregnant or breastfeeding women
Smoking or use of recreational drugs

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation: N/A
Model: Single group
Masking: Open label
Primary purpose: Prevention

Study locations

Pakistan · 1 center

Rehman Medical Institue — Peshawar

Publications

Basit et al. (2022). J Pak Med Assoc. (Health burden).
IDF Diabetes Atlas 2021 (Pakistan ranked 3rd in diabetes cases).

Identifiers

NCT: NCT07015788 · GL/GI-NA_1V5

Primary sources (government registries)

ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗